The Anti-fibrotic Hormone Relaxin is not Reno-protective, Despite Being Active, in an Experimental Model of Type 1 Diabetes

Publisher： Bentham Science Publishers

E-ISSN： 1875-5305|20|9|1029-1038

ISSN： 0929-8665

Source： Protein and Peptide Letters, Vol.20, Iss.9, 2013-06, pp. : 1029-1038

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Characterization of the Active Site and a Unique Uncompetitive Inhibitor of the PPM1-Type Protein Phosphatase PPM1D

By  

Protein and Peptide Letters, Vol. 15, Iss. 9, 2008-09 ,pp. : 938-948

Bentham Science Publishers

Access to resources Recommend Favorite

Relaxin and Nitric Oxide Signalling

By  

Current Protein and Peptide Science, Vol. 9, Iss. 6, 2008-12 ,pp. : 638-645

Bentham Science Publishers

Access to resources Recommend Favorite

Micro RNA: An Epigenetic Regulator of Type 2 Diabetes

By  

MicroRNA, Vol. 3, Iss. 2, 2014-01 ,pp. : 86-97

Bentham Science Publishers

Access to resources Recommend Favorite

Crystallization and Preliminary X-Ray Analysis of Anti-Obesity Peptide Hormone Oxyntomodulin

By  

Protein and Peptide Letters, Vol. 15, Iss. 2, 2008-02 ,pp. : 232-234

Bentham Science Publishers

Access to resources Recommend Favorite

The Neuropeptide Galanin Benefits Insulin Sensitivity in Subjects with Type 2 Diabetes

By  

Current Protein and Peptide Science, Vol. 14, Iss. 8, 2013-12 ,pp. : 669-673

Bentham Science Publishers

Access to resources Recommend Favorite